(Q43653668)
Statements
1 reference
Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study (English)
1 reference
E Paietta
1 reference
J L Liesveld
1 reference
J M Bennett
1 reference
M S Young
1 reference
K B Miller
1 reference
H M Lazarus
1 reference
R D Marsh
1 reference
W R Friedenberg
1 reference
H T Saba
1 reference
F A Hayes
1 reference
G W Dewald
1 reference
W Hiddemann
1 reference
J M Rowe
1 reference
1 January 2001
1 reference
1 reference
66
1 reference
1
1 reference
23-27
1 reference
Identifiers
1 reference
1 reference